Insulin pumps therapy is associated with better glycemic control and fewer complications, new study suggests.
Read More »Production Assistant, Diabetes In Control
Pen Demos
When recommending an insulin pen to a patient, do you have sample pens to demonstrate how to use properly? Follow the link to see how you compare to your colleagues.
Read More »Lifestyle Modifications
Your 42-year-old, overweight patient was diagnosed with type 2 diabetes (A1C 7.7%) five months ago. You discussed the diagnosis with him, prescribed metformin, and provided lifestyle modification education resources. He missed his follow-up appointment, so you called him to schedule a return visit. At this appointment, he shares some of the positive lifestyle modifications he has made and that he has been taking his metformin consistently. He currently takes 2,000 mg metformin per day. At this visit, his A1C is 9.4%. All of the following are reasonable treatment options EXCEPT: A. Metformin+ lifestyle modifications B. Metformin + once-daily evening basal insulin dose + lifestyle modifications C. Metformin + sulfonylurea+ lifestyle modifications D. Metformin + GLP-1 receptor agonist + lifestyle modifications Follow the link to see the correct answer.
Read More »Albuminuria: A Lot More Than Just a Little Protein in the Urine Part 9
In this week's Homerun Slides, testing albuminuria and potassium levels.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #95: Metabolomics: Applications in Type 2 Diabetes Mellitus and Insulin Resistance Part 1
Type 2 diabetes mellitus (T2DM) is not simply a disorder of blood sugar control, but a condition in which multiple biochemical pathways are impacted. An illustrative example of this is the elevated blood ketone body concentration typical of T2DM, which can progress to diabetic ketoacidosis if insulin action and/or availability deteriorates.The elevations of ketone bodies and the acetone accumulation (with associated “sweet breath odor”) of severe or poorly controlled diabetes are indicative of abnormal fatty acid homeostasis and specifically, high lipolysis and hepatic beta-oxidation.
Read More »Oct. 14, 2017
When I made the move from retail pharmacist to diabetes educator I had the opportunity to spend more time with patients and clinicians. Often the prescribers would express their frustration because they would constantly add on more medications with no improvement in results. Whenever I heard this frustration I would …
Read More »Diabetes Treatment Failure May Actually Be Nonadherence
Second-line treatment is often initiated without evidence of recommended use of first-line treatment.
Read More »The Effects Of Dietary Carbohydrate Restriction On Glucose-Lowering Effect In T2DM
Recent meta-analysis conducted to address ideal amount of dietary carbohydrates in the management of T2DM.
Read More »Dapagliflozin Added To Insulin For People with Type 1
Trial shows HbA1c reduced, hypoglycemia and DKA similar across study participants.
Read More »Hyperkalemia Associated With Poor Outcomes For Diabetes Patients
Increased risk for cardiac events, hospitalization clear predictors of death.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.